2009Qilu yixue zazhiRequires access

THE EFFICACY OF CEREBROSPINAL FLUID REPLACEMENT FOR TREATMENT OF AGED PATIENTS WITH SUBARACHNOID HEMORRHAGE

Qiangyuan Tian

Open publisher page 0 citations

Abstract

Objective To assess the clinical value of cerebrospinal fluid(CSF) replacement in the treatment of the aged with subarachnoid hemorrhage(SAH).MethodsSeventy-six SAH patients were equally divided into treatment group and control group in random and a routine medication was given.CSF replacement was added to the treatment group.The therapeutic efficacy,duration of symptoms,and complications were compared between the two groups after four weeks of therapy.ResultsThe therapeutic outcomes were superior in treatment group to the control in terms of shorter duration of symptoms,lower incidence of cerebral vascular spasm(CVS) and hydrocephalus(uc=6.567,t=9.686-19.713,χ2=3.952-6.725,P0.05) except for the recurrence rate of hemorrhage(χ2=1.815,P0.05).ConclusionCSF replacement is safe and effective for treatment of SAH in the aged.

About this research paper

What this paper is about

Objective To assess the clinical value of cerebrospinal fluid(CSF) replacement in the treatment of the aged with subarachnoid hemorrhage(SAH).MethodsSeventy-six SAH patients were equally divided into treatment group and control group in random and a routine medication was given.CSF replacement was added to the treatment group.The therapeutic efficacy,duration of symptoms,and complications were compared between the two groups after four weeks of therapy.ResultsThe therapeutic outcomes were superior in treatment group to the control in terms of shorter duration of symptoms,lower incidence of cerebral vascular spasm(CVS) and hydrocephalus(uc=6.567,t=9.686-19.713,χ2=3.952-6.725,P0.05) except for the recurrence rate of hemorrhage(χ2=1.815,P0.05).ConclusionCSF replacement is safe and effective for treatment of SAH in the aged.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To assess the clinical value of cerebrospinal fluid(CSF) replacement in the treatment of the aged with subarachnoid hemorrhage(SAH).MethodsSeventy-six SAH patients were equally divided into treatment group and control group in random and a routine medication was given.CSF replacement was added to the treatment group.The therapeutic efficacy,duration of symptoms,and complications were compared between the two groups after four weeks of therapy.ResultsThe therapeutic outcomes were superior in treatment group to the control in terms of shorter duration of symptoms,lower incidence of cerebral vascular spasm(CVS) and hydrocephalus(uc=6.567,t=9.686-19.713,χ2=3.952-6.725,P0.05) except for the recurrence rate of hemorrhage(χ2=1.815,P0.05).ConclusionCSF replacement is safe and effective for treatment of SAH in the aged.

Key concepts: Medicine, Subarachnoid hemorrhage, Cerebrospinal fluid, Fluid replacement, Incidence (geometry), Hydrocephalus, Anesthesia, Therapeutic effect

Related papers

Back to paper searchBrowse research topicsOriginal source
THE EFFICACY OF CEREBROSPINAL FLUID REPLACEMENT FOR TREATMENT OF AGED PATIENTS WITH SUBARACHNOID HEMORRHAGE — Research Paper | ScholarLens